IBDEI3I3 ; ; 19-NOV-2015
;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
Q:'DIFQR(358.4) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.4,499,0)
;;=PERITONEAL DIALYSIS ENCOUNTER^22^52
;;^UTILITY(U,$J,358.4,500,0)
;;=CARDIOLOGY/CARDIORENAL SYNDROME^2^52
;;^UTILITY(U,$J,358.4,501,0)
;;=COMPLICATIONS/OTHER^4^52
;;^UTILITY(U,$J,358.4,502,0)
;;=CYSTIC KIDNEY DISEASE^5^52
;;^UTILITY(U,$J,358.4,503,0)
;;=DIABETES/DIABETIC RENAL DISEASE^6^52
;;^UTILITY(U,$J,358.4,504,0)
;;=FLUID/ELECTROLYTE DISORDER^7^52
;;^UTILITY(U,$J,358.4,505,0)
;;=GENERAL SYMPTOMS^8^52
;;^UTILITY(U,$J,358.4,506,0)
;;=GENITAL/URINARY^9^52
;;^UTILITY(U,$J,358.4,507,0)
;;=HEMATOLOGY^11^52
;;^UTILITY(U,$J,358.4,508,0)
;;=HYPERTENSION^14^52
;;^UTILITY(U,$J,358.4,509,0)
;;=INFECTIOUS DISEASE^15^52
;;^UTILITY(U,$J,358.4,510,0)
;;=NEPHRITIS GLUMERULONEPHRITIS^17^52
;;^UTILITY(U,$J,358.4,511,0)
;;=NEPHRITIS INTERSTITIAL^18^52
;;^UTILITY(U,$J,358.4,512,0)
;;=NEPHROTIC SYNDROME^20^52
;;^UTILITY(U,$J,358.4,513,0)
;;=OBSTRUCTIVE UROPATHY^21^52
;;^UTILITY(U,$J,358.4,514,0)
;;=TRANSPLANT^24^52
;;^UTILITY(U,$J,358.4,515,0)
;;=CKD/KIDNEY DISEASE^3^52
;;^UTILITY(U,$J,358.4,516,0)
;;=HEMODIALYSIS-AKI^12^52
;;^UTILITY(U,$J,358.4,517,0)
;;=ACUTE KIDNEY INJURY^1^52
;;^UTILITY(U,$J,358.4,518,0)
;;=GLOMERULAR DISEASE^10^52
;;^UTILITY(U,$J,358.4,519,0)
;;=KIDNEY INVOLVMNT IN SYSTEMIC DISEASE^16^52
;;^UTILITY(U,$J,358.4,520,0)
;;=NEPHROLITHASIS^19^52
;;^UTILITY(U,$J,358.4,521,0)
;;=POISONING & INTOXICATIONS^23^52
;;^UTILITY(U,$J,358.4,522,0)
;;=CLINICIAN^1^53
;;^UTILITY(U,$J,358.4,523,0)
;;=PHARMACISTS^1^54
;;^UTILITY(U,$J,358.4,524,0)
;;=PHYSICAL THERAPISTS^2^54
;;^UTILITY(U,$J,358.4,525,0)
;;=RADIOLOGIST^4^54
;;^UTILITY(U,$J,358.4,526,0)
;;=PSYCHOLOGISTS^3^54
;;^UTILITY(U,$J,358.4,527,0)
;;=ACUTE RENAL FAILURE^1^55
;;^UTILITY(U,$J,358.4,528,0)
;;=CARDIOVASCULAR^2^55
;;^UTILITY(U,$J,358.4,529,0)
;;=CHRONIC KIDNEY DISEASE^3^55
;;^UTILITY(U,$J,358.4,530,0)
;;=CONTACT/EXPOSURE TO COM D^4^55
;;^UTILITY(U,$J,358.4,531,0)
;;=DERMATOLOGY^5^55
;;^UTILITY(U,$J,358.4,532,0)
;;=DIABETES W/ COMPLICATIONS^6^55
;;^UTILITY(U,$J,358.4,533,0)
;;=DIABETES W/O COMPLICATION^7^55
;;^UTILITY(U,$J,358.4,534,0)
;;=EENT^8^55
;;^UTILITY(U,$J,358.4,535,0)
;;=ENDOCRINE/METABOLIC^9^55
;;^UTILITY(U,$J,358.4,536,0)
;;=GASTROENTEROLOGY^10^55
;;^UTILITY(U,$J,358.4,537,0)
;;=GENITOURINARY^11^55
;;^UTILITY(U,$J,358.4,538,0)
;;=HEMATOLOGY/ONCOLOGY^12^55
;;^UTILITY(U,$J,358.4,539,0)
;;=HISTORY & STATUS POST^13^55
;;^UTILITY(U,$J,358.4,540,0)
;;=INFECTIOUS DISEASE^14^55
;;^UTILITY(U,$J,358.4,541,0)
;;=INFLAMMATORY/INF LUNG DX^15^55
;;^UTILITY(U,$J,358.4,542,0)
;;=INTERSTITIAL DISEASE^16^55
;;^UTILITY(U,$J,358.4,543,0)
;;=MENTAL HEALTH^17^55
;;^UTILITY(U,$J,358.4,544,0)
;;=MUSCULOSKELETAL^18^55
;;^UTILITY(U,$J,358.4,545,0)
;;=NEUROLOGY^19^55
;;^UTILITY(U,$J,358.4,546,0)
;;=OBSTRUCTIVE AIRWAY DISEASE^20^55
;;^UTILITY(U,$J,358.4,547,0)
;;=ORAL CAVITY^21^55
;;^UTILITY(U,$J,358.4,548,0)
;;=OTHER REASONS^22^55
;;^UTILITY(U,$J,358.4,549,0)
;;=PAIN^23^55
;;^UTILITY(U,$J,358.4,550,0)
;;=PERSONAL HX OF CANCER^24^55
;;^UTILITY(U,$J,358.4,551,0)
;;=PLEURAL DISEASE^25^55
;;^UTILITY(U,$J,358.4,552,0)
;;=PNEUMONIA^26^55
;;^UTILITY(U,$J,358.4,553,0)
;;=PULMONARY VASCULAR DISEASE^27^55
;;^UTILITY(U,$J,358.4,554,0)
;;=RESPIRATORY^28^55
;;^UTILITY(U,$J,358.4,555,0)
;;=SECONDARY DIABETES^29^55
;;^UTILITY(U,$J,358.4,556,0)
;;=SIGNS, SYMPTOMS, CONDITIONS^30^55
;;^UTILITY(U,$J,358.4,557,0)
;;=SLEEP DISORDERS^31^55
;;^UTILITY(U,$J,358.4,558,0)
;;=THROMBO EMBOLIC DISEASE^32^55
;;^UTILITY(U,$J,358.4,559,0)
;;=TUMOR^33^55
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI3I3 3946 printed Apr 09, 2024@20:55:36 Page 2
IBDEI3I3 ; ; 19-NOV-2015
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
+2 if 'DIFQR(358.4)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,99)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.4,499,0)
+2 ;;=PERITONEAL DIALYSIS ENCOUNTER^22^52
+3 ;;^UTILITY(U,$J,358.4,500,0)
+4 ;;=CARDIOLOGY/CARDIORENAL SYNDROME^2^52
+5 ;;^UTILITY(U,$J,358.4,501,0)
+6 ;;=COMPLICATIONS/OTHER^4^52
+7 ;;^UTILITY(U,$J,358.4,502,0)
+8 ;;=CYSTIC KIDNEY DISEASE^5^52
+9 ;;^UTILITY(U,$J,358.4,503,0)
+10 ;;=DIABETES/DIABETIC RENAL DISEASE^6^52
+11 ;;^UTILITY(U,$J,358.4,504,0)
+12 ;;=FLUID/ELECTROLYTE DISORDER^7^52
+13 ;;^UTILITY(U,$J,358.4,505,0)
+14 ;;=GENERAL SYMPTOMS^8^52
+15 ;;^UTILITY(U,$J,358.4,506,0)
+16 ;;=GENITAL/URINARY^9^52
+17 ;;^UTILITY(U,$J,358.4,507,0)
+18 ;;=HEMATOLOGY^11^52
+19 ;;^UTILITY(U,$J,358.4,508,0)
+20 ;;=HYPERTENSION^14^52
+21 ;;^UTILITY(U,$J,358.4,509,0)
+22 ;;=INFECTIOUS DISEASE^15^52
+23 ;;^UTILITY(U,$J,358.4,510,0)
+24 ;;=NEPHRITIS GLUMERULONEPHRITIS^17^52
+25 ;;^UTILITY(U,$J,358.4,511,0)
+26 ;;=NEPHRITIS INTERSTITIAL^18^52
+27 ;;^UTILITY(U,$J,358.4,512,0)
+28 ;;=NEPHROTIC SYNDROME^20^52
+29 ;;^UTILITY(U,$J,358.4,513,0)
+30 ;;=OBSTRUCTIVE UROPATHY^21^52
+31 ;;^UTILITY(U,$J,358.4,514,0)
+32 ;;=TRANSPLANT^24^52
+33 ;;^UTILITY(U,$J,358.4,515,0)
+34 ;;=CKD/KIDNEY DISEASE^3^52
+35 ;;^UTILITY(U,$J,358.4,516,0)
+36 ;;=HEMODIALYSIS-AKI^12^52
+37 ;;^UTILITY(U,$J,358.4,517,0)
+38 ;;=ACUTE KIDNEY INJURY^1^52
+39 ;;^UTILITY(U,$J,358.4,518,0)
+40 ;;=GLOMERULAR DISEASE^10^52
+41 ;;^UTILITY(U,$J,358.4,519,0)
+42 ;;=KIDNEY INVOLVMNT IN SYSTEMIC DISEASE^16^52
+43 ;;^UTILITY(U,$J,358.4,520,0)
+44 ;;=NEPHROLITHASIS^19^52
+45 ;;^UTILITY(U,$J,358.4,521,0)
+46 ;;=POISONING & INTOXICATIONS^23^52
+47 ;;^UTILITY(U,$J,358.4,522,0)
+48 ;;=CLINICIAN^1^53
+49 ;;^UTILITY(U,$J,358.4,523,0)
+50 ;;=PHARMACISTS^1^54
+51 ;;^UTILITY(U,$J,358.4,524,0)
+52 ;;=PHYSICAL THERAPISTS^2^54
+53 ;;^UTILITY(U,$J,358.4,525,0)
+54 ;;=RADIOLOGIST^4^54
+55 ;;^UTILITY(U,$J,358.4,526,0)
+56 ;;=PSYCHOLOGISTS^3^54
+57 ;;^UTILITY(U,$J,358.4,527,0)
+58 ;;=ACUTE RENAL FAILURE^1^55
+59 ;;^UTILITY(U,$J,358.4,528,0)
+60 ;;=CARDIOVASCULAR^2^55
+61 ;;^UTILITY(U,$J,358.4,529,0)
+62 ;;=CHRONIC KIDNEY DISEASE^3^55
+63 ;;^UTILITY(U,$J,358.4,530,0)
+64 ;;=CONTACT/EXPOSURE TO COM D^4^55
+65 ;;^UTILITY(U,$J,358.4,531,0)
+66 ;;=DERMATOLOGY^5^55
+67 ;;^UTILITY(U,$J,358.4,532,0)
+68 ;;=DIABETES W/ COMPLICATIONS^6^55
+69 ;;^UTILITY(U,$J,358.4,533,0)
+70 ;;=DIABETES W/O COMPLICATION^7^55
+71 ;;^UTILITY(U,$J,358.4,534,0)
+72 ;;=EENT^8^55
+73 ;;^UTILITY(U,$J,358.4,535,0)
+74 ;;=ENDOCRINE/METABOLIC^9^55
+75 ;;^UTILITY(U,$J,358.4,536,0)
+76 ;;=GASTROENTEROLOGY^10^55
+77 ;;^UTILITY(U,$J,358.4,537,0)
+78 ;;=GENITOURINARY^11^55
+79 ;;^UTILITY(U,$J,358.4,538,0)
+80 ;;=HEMATOLOGY/ONCOLOGY^12^55
+81 ;;^UTILITY(U,$J,358.4,539,0)
+82 ;;=HISTORY & STATUS POST^13^55
+83 ;;^UTILITY(U,$J,358.4,540,0)
+84 ;;=INFECTIOUS DISEASE^14^55
+85 ;;^UTILITY(U,$J,358.4,541,0)
+86 ;;=INFLAMMATORY/INF LUNG DX^15^55
+87 ;;^UTILITY(U,$J,358.4,542,0)
+88 ;;=INTERSTITIAL DISEASE^16^55
+89 ;;^UTILITY(U,$J,358.4,543,0)
+90 ;;=MENTAL HEALTH^17^55
+91 ;;^UTILITY(U,$J,358.4,544,0)
+92 ;;=MUSCULOSKELETAL^18^55
+93 ;;^UTILITY(U,$J,358.4,545,0)
+94 ;;=NEUROLOGY^19^55
+95 ;;^UTILITY(U,$J,358.4,546,0)
+96 ;;=OBSTRUCTIVE AIRWAY DISEASE^20^55
+97 ;;^UTILITY(U,$J,358.4,547,0)
+98 ;;=ORAL CAVITY^21^55
+99 ;;^UTILITY(U,$J,358.4,548,0)
+100 ;;=OTHER REASONS^22^55
+101 ;;^UTILITY(U,$J,358.4,549,0)
+102 ;;=PAIN^23^55
+103 ;;^UTILITY(U,$J,358.4,550,0)
+104 ;;=PERSONAL HX OF CANCER^24^55
+105 ;;^UTILITY(U,$J,358.4,551,0)
+106 ;;=PLEURAL DISEASE^25^55
+107 ;;^UTILITY(U,$J,358.4,552,0)
+108 ;;=PNEUMONIA^26^55
+109 ;;^UTILITY(U,$J,358.4,553,0)
+110 ;;=PULMONARY VASCULAR DISEASE^27^55
+111 ;;^UTILITY(U,$J,358.4,554,0)
+112 ;;=RESPIRATORY^28^55
+113 ;;^UTILITY(U,$J,358.4,555,0)
+114 ;;=SECONDARY DIABETES^29^55
+115 ;;^UTILITY(U,$J,358.4,556,0)
+116 ;;=SIGNS, SYMPTOMS, CONDITIONS^30^55
+117 ;;^UTILITY(U,$J,358.4,557,0)
+118 ;;=SLEEP DISORDERS^31^55
+119 ;;^UTILITY(U,$J,358.4,558,0)
+120 ;;=THROMBO EMBOLIC DISEASE^32^55
+121 ;;^UTILITY(U,$J,358.4,559,0)
+122 ;;=TUMOR^33^55
